E L Snyder
Overview
Explore the profile of E L Snyder including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
105
Citations
754
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Tadokoro K, Reesink H, Panzer S, Chabanel A, Santailler G, Guerin T, et al.
Vox Sang
. 2009 Sep;
98(1):78-84.
PMID: 19754524
No abstract available.
2.
Pelletier J, Transue S, Snyder E
Best Pract Res Clin Haematol
. 2005 Dec;
19(1):205-42.
PMID: 16377551
The desire to rid the blood supply of pathogens of all types has led to the development of many technologies aimed at the same goal--eradication of the pathogen(s) without harming...
3.
Fisk J, Snyder E
Dev Biol (Basel)
. 2005 Jul;
120:39-44.
PMID: 16050154
In conclusion, as of 2004, it appears that in the United States in some hospitals, the use of LR blood products will probably remain as SLR rather than PSULR, due...
4.
Burgess J, Mills B, Griffith M, Mansour V, Weaver C, Schwartzberg L, et al.
Cytotherapy
. 2002 Aug;
3(4):285-94.
PMID: 12171717
Background: Positive selection of CD34(+) cells may reduce or eliminate tumor cells contaminating PBSC harvests of breast cancer (BrCa) patients. However, to assess tumor purging accurately methods may be needed...
5.
Snyder E, Dodd R
Hematology Am Soc Hematol Educ Program
. 2001 Nov;
:433-42.
PMID: 11722997
There are continuing concerns over the safety of the nation's and the world's blood supply. The allogeneic blood supply is tested for antibodies to HIV1/2, HTLVI/II, hepatitis B, hepatitis C...
6.
Wang T, Kobayashi T, Takimoto R, Denes A, Snyder E, El-Deiry W, et al.
EMBO J
. 2001 Nov;
20(22):6404-13.
PMID: 11707411
The tumor suppressor protein p53 is a transcription factor that is frequently mutated in human cancers. In response to DNA damage, p53 protein is stabilized and activated by post-translational modifications...
7.
8.
Snyder E, ODonnell L, Dengler T, Pomper G, Velleca M, Dincecco D, et al.
Transfusion
. 2001 Jul;
41(7):940-9.
PMID: 11452164
Background: This study reports on an evaluation of the ability of a cell separator (Amicus, Baxter Healthcare) and the integral MNC computer software program to collect a variety of MNC...
9.
Perrotta P, Snyder E
Blood Rev
. 2001 Jun;
15(2):69-83.
PMID: 11409907
Blood transfusion is considered safe when the infused blood is tested using state of the art viral assays developed over the past several decades. Only rarely are known viruses like...
10.
Snyder E, Dowdy S
Curr Opin Mol Ther
. 2001 May;
3(2):147-52.
PMID: 11338927
In vivo gene delivery can be achieved by direct injection of plasmid DNA. However, inefficient cellular uptake and nuclear import of plasmid DNA result in much lower levels of gene...